Government and public-private coalitions have important roles in cancer surveillance in LMICs.

Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach.

Inequity makes it imperative to consider how trade and patent policies influence international patients’ access to treatment and prevention.

Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake.

Redirecting focus from treatment to prevention is a global public health imperative.

HPV tests are alternatives to Pap smear screening that enable women to self-collect specimens and might be the best cervical cancer prevention strategy for many.

Cervical cancer has become rare in high-income countries but is a leading cause of mortality among women in low- and middle-income countries. This inequity is an epidemiological tragedy.

African cancer research is embedded in underresourced health care infrastructures, illuminating ethical questions about benefit sharing and governance.

IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations.

Upcoding and misrepresenting clinical information constitute fraud, cost a lot, and can result in patient harm and unnecessary procedures and prescriptions.